Suggest a Paper for the 2027 ISTAART Year in Review Webinars
Suggest the 2026 papers that stood out in your field for ISTAART’s 2027 Year in Review webinars. Suggestions close on 7 December 2026.
All posts by Alzheimer's Association
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support.
Call for Papers: Expanding the Reach of Dementia Clinical Trials
npj Dementia wants papers on dementia trial design, recruitment and lessons from the field, with coordinators and early career voices encouraged.
Propose an ISTAART Immersive Workshop for AAIC 2027
ISTAART members can propose half- or full-day hands-on workshops to run before AAIC 2027 in Chicago, on 16 and 17 July 2027. Proposals close 13 November 2026.
Call for Papers: Exceptional Aging Special Issue
TRCI wants original research, reviews and perspectives on exceptional aging in later life, from cognition and mobility to biological resilience and mixed pathology.
Become a Grant Reviewer for the Alzheimer’s Association
ISTAART members are invited to register interest in peer reviewing grant applications for the Alzheimer’s Association International Research Grant Program.
ISTAART Launches Two New Professional Interest Areas
ISTAART launches two new PIAs on physical activity and post-traumatic neurodegeneration. Join now to connect, collaborate and shape dementia research.
Blood Test May Predict Alzheimer’s Risk 10 Years Early
A blood test measuring p-tau217 may predict Alzheimer’s-related cognitive decline up to a decade before symptoms appear, AAIC 2026 research finds.
Alzheimer’s Blood Test Could Transform Diagnosis
New data suggest an Alzheimer’s blood test could help primary care doctors diagnose the disease with around 90% accuracy, matching specialists. #AAIC26
LiBBY Trial: THC/CBD Reduces End-of-Life Agitation
Phase 2 LiBBY trial results suggest a THC/CBD combination rapidly and significantly reduces agitation in hospice-eligible people with dementia. #AAIC26
PROTECT-Cog Tests Lifestyle and GLP-1 for Cognitive Decline
A new $100m global trial will test whether combining lifestyle support with GLP-1 or similar drugs can reduce cognitive decline and dementia risk.
Lifestyle Programme Boosts Brain Health Across Latin America
Lifestyle changes improved memory and thinking in older adults at risk of dementia across Latin America, with coaching delivering the strongest gains.
Former Elite Soccer Players Show Evidence of Brain Health Changes in Mid-Life
Research presented by Caleigh Grace Lynch presneted at AAIC provides insights into brain health among former elite professional soccer players during midlife.